Type of cell therapy does not improve walking ability for patients with peripheral artery disease
Joseph Poole, M.D., Ph.D., of the Emory University School of Medicine, Atlanta, and colleagues studied whether therapy with granulocyte-macrophage colony stimulating factor (GM-CSF), an agent that functions as a white blood ...
Nov 18, 2013
0
0